bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.05.13.540536

MSCProfiler: An image processing workflow to investigate Mesenchymal Stem Cell heterogeneity using imaging flow cytometry data.

Abstract

Single-cell immuno-heterogeneity has always been the forerunner of any change in homeostasis of cellular functions in the body. Mesenchymal stem cells represent a viable source for the development of cell-based therapies. Multiple conditions giving rise to inter, and intra-population variations result in heterogeneity and multipotent differentiation ability of these cells of stromal origin. Cell surface markers which are important members of membrane proteins, ion channels, transporter, adhesion, and signaling molecules generally differentiate between stromal cells of different origin. However, existing analytical tools cannot always model a pattern of their surface distribution in successive generations of growth and proliferation. In this study, we have developed a post-acquisition image analysis pipeline for human mesenchymal stromal cells obtained from exfoliated deciduous teeth (hSHEDs). Using the open-source image processing software CellProfiler, a pipeline has been developed to extract cellular features from 50,000-100,000 single-cell images. We made use of the image flow cytometry technology to explore the morphometric properties of hSHEDs, along with their surface marker distribution. This unbiased pipeline can extract cellular, geometrical and texture features such as shape, size, eccentricity, entropy, intensities as a measure of cellular heterogeneity. For the first time, we have described an automated, unbiased image assessment protocol implemented in a validated open-source software, leveraging the suite of image-based measurements to develop the prototype named as MSCProfiler. The hallmark of this screening workflow has been the identification and removal of image-based aberrations to identify the single-cell bright field and fluorescent images of mesenchymal stem cells.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gupta, A., Shaik, S., Balasubramanian, L., Chakraborty, U.. 2023-05-14. MSCProfiler: An image processing workflow to investigate Mesenchymal Stem Cell heterogeneity using imaging flow cytometry data.. https://doi.org/10.1101/2023.05.13.540536

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗

Tracking the conformational dynamics of single molecules in live cells; GTPase cycling in Cdc42 gradients and microclusters

The Rho family of GTPases play a critical role in many cellular processes by acting as molecular switches relying on conformational changes to transition between active and inactive states. The spatial distribution and kinetics of these conformational changes are complex and vary across the cell. We describe here biosensors based on environment-responsive fluorescent dyes, capable of reporting the conformational changes of individual GTPase molecules as they traffic within living cells (SPARC Cdc42 and SPARC Rac1, 'Single Particle Activation Reporter Constructs'). We use SPARC Cdc42 to determine the rates of different steps in GTPase regulation, activation/inactivation and membrane insertion, that together generate localized gradients of Cdc42 activity driving cell motility. The biosensors also revealed heterogeneously distributed clusters of Cdc42, the mechanisms of their activation, and potential roles in polarized motility.

cell biology↗

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗